At a glance
- Originator Banyu
- Class Antihyperlipidaemics
- Mechanism of Action Squalene synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hypercholesterolaemia
Most Recent Events
- 30 May 2001 Profile reviewed but no significant changes made
- 03 Sep 1998 No-Development-Reported for Hypercholesterolaemia in Japan (Unknown route)
- 30 Nov 1995 New profile